Publication Date
2014
Journal Title
J Clin Microbiol
Abstract
The incidence of aztreonam and cephalosporin susceptibility, determined using the revised CLSI breakpoints, for extendedspectrum-beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolates was evaluated. Our analysis showed that results for aztreonam and/or> 1 cephalosporin were reported as susceptible or intermediate for 89.2% of ESBLproducing E coli isolates (569/638 isolates) and 67.7% of ESBL-producing K. pneumoniae isolates (155/229 isolates).
Volume Number
52
Issue Number
7
Pages
2653-2655
Document Type
Article
EPub Date
2014/05/03
Status
Faculty, Northwell Researcher
Facility
School of Medicine; Northwell Health
Primary Department
Occupational Medicine, Epidemiology and Prevention
Additional Departments
Pathology and Laboratory Medicine; Molecular Medicine
PMID
DOI
10.1128/jcm.03613-13
COinS